Somaxon Pharmaceuticals to Report Third Quarter 2012 Results and Conduct
Conference Call on Wednesday, October 31
SAN DIEGO, Oct. 22, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc.
(Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it
will release its financial results for the third quarter ended September 30,
2012 on Wednesday, October 31, 2012 after the close of the U.S. financial
markets. The Company will also conduct a conference call that same afternoon
at 4:30 p.m. ET (1:30 p.m. PT) to discuss results and highlights of the third
quarter of 2012.
The conference call will be available to interested parties through a live
audio webcast at http://investors.somaxon.com/events.cfm. The webcast will
also be archived and accessible at this site for one year. Alternatively,
callers may participate in the live conference call by dialing (877) 941-9205
(domestic) or (480) 629-9771 (international), conference call ID 4570871. A
telephonic replay will be available for approximately two weeks following the
conclusion of the call by dialing (303) 590-3030, and entering passcode
About Somaxon Pharmaceuticals, Inc.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty
pharmaceutical company focused on the in-licensing, development and
commercialization of proprietary branded products and late-stage product
candidates to treat important medical conditions where there is an unmet
medical need and/or high-level of patient dissatisfaction, currently in the
central nervous system therapeutic area. Somaxon's product Silenor, now
available by prescription in the United States, is indicated for the treatment
of insomnia characterized by difficulty with sleep maintenance.
The Somaxon Pharmaceuticals logo is available at
For more information, please visit the company's web site at www.somaxon.com.
CONTACT: Tran Nguyen / CFO
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.